Biomerica
BMRA
7 hedge funds and large institutions have $539K invested in Biomerica in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
24% more capital invested
Capital invested by funds: $435K → $539K (+$104K)
17% more funds holding
Funds holding: 6 → 7 (+1)
0.04% more ownership
Funds ownership: 0.16% → 0.2% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$70.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.43K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $361K | +$5.16K | +170 | +1% |
|
|
2
BlackRock
New York
| $72K | +$70.9K | +2,336 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $50K | +$48.3K | +1,592 | New |
|
4
Wells Fargo
San Francisco,
California
| $25K | – | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $15K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $12K | +$5.43K | +179 | +82% |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $3.89K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$13K | -397 | Closed |
|
BMRA Hedge Fund Activity: Q2 2018 in Review
7 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q2 2018, worth a combined $539K — up 24% from $435K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BMRA positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $70.9K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $13K sold.
- 7 institutional investors held Biomerica (BMRA) as of Q2 2018, up from 6 in Q1 2018.
- Funds reported $539K of Biomerica stock for Q2 2018, up 24% quarter-over-quarter.
- 2 funds opened new Biomerica positions in Q2 2018 and 1 closed out, a net change of +1 holder.
- The largest Biomerica buyer in Q2 2018 was BlackRock, an estimated $70.9K added.
- The largest Biomerica seller in Q2 2018 was Tower Research Capital (TRC), an estimated $13K sold.
Based on aggregated 13F filings for Q2 2018.